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http://dx.doi.org/10.1016/j.pedneo.2Background: Sepsis is an important cause of neonatal death and perinatal brain damage,
particularly in preterm infants. It is thought that activation of the inflammatory cascade trig-
gered by cytokine might play a role in the pathogenesis of sepsis. Recent evidence supports a
role for resistin in inflammation. There are no data in the literature on resistin levels of pre-
mature newborns with sepsis, which can also cause inflammatory response. The objective of
this study was to evaluate whether resistin can be used as an indicator in neonatal sepsis of
preterm babies.
Materials and methods: Forty-three premature newborns considered to have sepsis were
included in the study. Forty-three gestational and postnatal age- and sex-matched premature
newborns without premature prolonged rupture of membrane or sepsis served as controls.
Results: The median resistin and interleukin-6 (IL-6) levels of the premature babies with sepsis
were 85.9 ng/mL and 342.7 pg/mL, respectively, and were higher than those of the control
group (29.9 ng/mL and 17.7 pg/mL, respectively). The sensitivity, specificity, positive, and
negative predictive values for resistin were 73.7%, 45.8%, 68.3%, and 52.4%, respectively.
Conclusion: Resistin levels were higher in premature newborns with sepsis and correlated with
IL-6 levels, which is an indicator of neonatal sepsis. This suggests that resistin may also be used
in the diagnosis of neonatal sepsis. However, it has limited value when compared with the
other inflammatory markers including C-reactive protein, procalcitonin, and IL-6.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.si, Altınbel Villaları 40/B, Mutlukent Mahallesi, Ankara, Turkey.
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54 D. Aliefendioglu et al1. Introduction
Sepsis is one of the most important diseases in preterm
babies and is responsible for 45% of late deaths in the
neonatal intensive care units (NICUs).1 Early diagnosis and
treatment of the newborn infant with suspected sepsis are
essential to prevent severe and life-threatening complica-
tions. Compared with the clear and valuable therapeutic
options, the diagnosis of suspected neonatal sepsis is
challenging. In preterm infants, the diagnosis of sepsis is
more difficult, because of the nonspecific clinical presen-
tation and the lack of reliable diagnostic tests.2 Blood
culture is the gold standard for the diagnosis of sepsis in
newborns. However, technical problems such as insufficient
blood sample or maternal antibiotic usage can be a barrier
in isolating the responsible pathogens.
In recent years there has been great interest in the po-
tential diagnostic value of a range of hematological and
immunological surrogate indicators of infection, and the
studies in adults and children have demonstrated the
important role of interleukin-6 (IL-6), IL-8, C-reactive pro-
tein (CRP), and procalcitonin (PCT) in the diagnosis of
sepsis.2,3 Resistin is a newly discovered metabolic hormone
and it has been implicated in adipogenesis and in the
development of insulin resistance.4 In mice, resistin is
mainly secreted by adipocyte, whereas in humans, it is
expressed and/or secreted by mononuclear cells, macro-
phages, and neutrophils.5 The initial studies showed the
relationship between resistin levels and anthropometric
parameters in neonates, and resistin was suggested to be
involved in the maintenance of neonatal metabolic ho-
meostasis.6 However, recent studies showed the role of
resistin in inflammation and there is emerging evidence
that resistin may also function as a proinflammatory agent.7
Studies in adult patients with sepsis demonstrated that
resistin expression and secretion by macrophages and
neutrophils are elevated in the presence of acute bacterial
infection.8e10 In addition, it has been emphasized that
resistin is an indicator of the severity of disease and
possibly a mediator of the prolonged inflammatory state
seen in critically ill patients with infection.9 Limited data
are available on resistin levels in neonatal sepsis, which can
also cause an inflammatory response.11 The objective of
this study was to evaluate whether resistin can be used as
an indicator in neonatal sepsis of preterm babies.
2. Materials and Methods
2.1. Patients
The study was approved by the local ethics committee.
Informed consents were obtained from the families of the
infants included in the study. Forty-three premature new-
borns (19 male and 24 female) considered to have sepsis
were included in the study; 43 gestational and postnatal
age- and gender-matched newborns without premature
prolonged rupture of membrane (PPROM) or sepsis served
as controls.
Sepsis was diagnosed based on clinical and laboratory
findings, and positive culture results. the clinical findings of
sepsis included apnea, gastrointestinal problems, increasedneed for oxygen or ventilatory support, lethargy/hypoto-
nia, and hypotension. The components of the laboratory
investigation are hematological counts and ratios such as
total leukocyte count, absolute neutrophil count, throm-
bocyte count, immature-to-total neutrophil ratio, and
serum or plasma concentrations of the acute-phase pro-
teins such as CRP and PCT. Sepsis was suspected if the in-
fant had any of the aforementioned clinical signs and two
or more laboratory parameters had abnormal values. Sub-
sequently, a blood culture was performed to confirm sepsis.
A positive blood culture confirms the diagnosis of sepsis.
2.2. Blood samples
Venous blood samples were drawn to measure whole blood
count, resistin, IL-6, CRP, and PCT level on the 1st day of
sepsis. Levels of resistin and IL-6 were further determined
on the 3rd and 7th days of sepsis. The CRP levels were
quantitatively evaluated by the nephelometric method
using a CardioPhase hsCRP kit (Dade Behring, Marburg,
Germany) on a nephelometer (BN II Nephelometer;
Siemens, Dade Behring, Marburg, Germany). The PCT levels
were analyzed by the luminescence method using a PCT kit
(B.R.A.H.M.S. Diagnostica, Berlin, Germany) on a liaison
analyzer (DiaSorin S.p.A., Saluggia, Vercelli, Italy). The IL-6
concentrations (BioSource International, Camarillo, CA,
USA) and resistin levels (LINCO Research, St. Charles, MO,
USA) were determined using enzyme-linked immunosorbent
assay kit.
2.3. Statistics
Data were expressed as mean  standard deviation for
normally distributed continuous variables or median
(minemax values) for skewed continuous variables and as
proportions for categorical variables. A p value <0.05 was
considered statistically significant. Differences were
analyzed between the groups by Student t test when data
were normally distributed; otherwise, ManneWhitney U
test was used. Correlations were analyzed by Spearman
correlation test. The receiver operating characteristics
(ROC) curve analysis was performed to identify the optimal
cutoff value for resistin to distinguish between the cases
with sepsis and the healthy cases.3. Results
Mean gestational age, mean birth weight, and male-to-
female ratio of the babies included in the study are shown
in Table 1.
Forty-three premature newborns with sepsis were
included in the study and a pathogen could be isolated in
75% of them. The isolated microorganisms were as follows:
methicillin-resistant Staphylococcus aureus in nine cases,
methicillin-resistant Staphylococcus epidermidis in three
cases, Streptococcus agalactiae in one case, S. aureus in
three cases, Enterococcus faecalis in two cases, Klebsiella
species in four cases, Escherichia coli in six cases, Pseu-
domonas aeruginosa in one case, Enterobacter aerogenes
in one case, and Candida species in two cases.
Table 1 Demographic characteristics of the premature newborns with sepsis and controls.
Control group (n Z 43) Study group (n Z 43) p
Gestational age (wk) 30  3 (23.5e35) 30  4 (24e36.3) 0.58
Birth weight (g) 1448  428 (700e2800) 1394  592 (545e2800) 0.63
Gender (M/F) 22/21 19/24 0.52
Data are presented as mean  standard deviation (minemax values).
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the study and the control groups. Both resistin and IL-6
levels substantially decreased on the 3rd and 7th days of
sepsis and positive correlations were observed between
them (Figure 1).
A positive correlation was observed between IL-6 and
PCT levels on the 1st day of sepsis (r Z 0.49, p Z 0.006).
However, IL-6 was positively correlated with CRP only on
the 3rd day of sepsis (rZ 0.7, pZ 0.000). The cutoff value
for resistin that can be used to distinguish the babies with
sepsis from healthy ones was found to be 50 ng/mL. The
area under the curve value for resistin was 0.74 (95% con-
fidence interval Z 0.63e0.85; p < 0.001). However, the
area under the curve for the remaining parameters, such as
CRP, PCT, and IL-6 were 0.94, 0.86, and 0.83, respectively.
The sensitivity, specificity, positive, and negative predic-
tive values for this cutoff value were 74%, 46%, 68%, and
52%, respectively.
4. Discussion
In this study, we showed that median resistin levels of the
babies with sepsis were significantly higher than those
without sepsis, and there were significant correlations be-
tween IL-6 and resistin levels in babies with sepsis. It has
been thought that activation of the inflammatory cascade
triggered by cytokine may play a role in the pathogenesis of
sepsis.12,13 The first step of the inflammatory response is
largely characterized by an influx of neutrophils.14 The
switch in leukocyte recruitment involves IL-6 trans-
signaling.15 IL-6 is a well-known biomarker of inflammatory
response that alters the expression of other inflammatory
proteins.6 Besides its direct proinflammatory effects, IL-6
also increases resistin messenger RNA expression in
human peripheral blood mononuclear cells.16
As previously mentioned, resistin, originally described as
an adipokine, has emerged as a potent proinflammatory
protein associated with inflammation, and its role in bothTable 2 C-reactive protein, procalcitonin, interleukin-6, and
compared with control.
Control group (n Z 43)
CRP (mg/L) 0.1 (0.1e5.7)
PCT (ng/mL) 0.1 (0.1e3.18)
IL-6 (pg/mL) 17.7 (2e2500)
Resistin (ng/mL) 29.9 (7.2e176.7)
Data are presented as median (minemax values).
CRP Z C-reactive protein; IL-6 Z interleukin-6; PCT Z procalcitoninacute and chronic inflammation has been shown.17e19
Recently, we showed that resistin levels were higher in
neonates with PPROM than those without PPROM.20 In
addition, we observed that the babies of mothers who had
received antenatal steroids had significantly lower resistin
levels than those who had not. Therefore, we thought that
elevated resistin levels in babies with PPROM and sup-
pressed levels in babies whose mothers received antenatal
steroids might have been due to fetal inflammation on
resistin levels. The findings of our study reported herein
support the role of resistin in the regulation of inflamma-
tory responses in premature newborns. However, no
research showing its relationship with inflammation in ne-
onates has been carried out.
Similarly, there are limited data in the literature on
resistin levels of premature newborns with sepsis. Recently,
Cekmez et al11 investigated the predictive value of resistin
in near-term and term babies with sepsis and they showed
that resistin could be used in the diagnosis of neonatal
sepsis with a similar efficacy as other markers such as CRP,
PCT, and IL-6.
In adult patients with sepsis, resistin has been proposed
as a powerful indicator of sepsis severity, as well as a
predictor of survival of critically ill patients. Johansson
et al9 investigated the resistin levels in adult patients with
severe sepsis and septic shock, and they showed that
resistin is a marker of severity of disease and possibly a
mediator of the prolonged inflammatory state seen in
infected critically ill patients. Similarly, in the study by
Koch and co-workers,21 serum resistin levels were investi-
gated in critically ill adult patients, and the authors high-
lighted that resistin has a role as an acute-phase protein in
critical-care circumstances. In the same study, they also
observed a strong correlation between resistin levels and
CRP, IL-6, and tumor necrosis factor-a. However, we could
not find any association between resistin and these
parameters except for IL-6. It is believed that PCT is
produced by the liver and peripheral blood mononuclearplasma resistin levels in babies with sepsis (on the 1st day)
Study group (n Z 43) p
2.32 (0.1e23.1) 0.000
1.80 (0.1e90) 0.000
342.7 (2e3184) 0.001
85.9 (17.5e229.9) 0.001
.
Figure 1 Correlations between plasma resistin and
interleukin-6 (IL-6) levels in the patients with sepsis (A) on the 1s
day of sepsis (rZ 0.46, pZ 0.003); (B) on the 3rd day (rZ 0.55,
pZ 0.002); and (C) on the 7th day (rZ 0.52, pZ 0.01).
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cytokines.22 Cytokines such as IL-6 and IL-8 are also
induced by lipopolysaccharides or other bacterial com-
pounds and are potentially valuable parameters in the early
diagnosis of bacterial sepsis as their levels are increased
even before infants develop any clinical symptoms and
routine laboratory tests become positive.23 The CRP, which
is widely used as a parameter in the diagnosis of sepsis is
also synthesized by the liver, mainly in response to IL-6. IL-6
drives the acute-phase response based on IL-6-response
elements within the promoter region of CRP and thus the
increase in CRP follows that of IL-6. Interestingly, in our
study, the correlation between IL-6 and CRP was observed
on the 3rd day of sepsis, while the correlation with PCT was
observed on the 1st day of sepsis. However, although both
are diagnostic markers of infection, PCT increased and
returned to the normal range quicker than CRP, suggesting
that PCT may be an early marker of a favorable outcome.24
It has been reported that PCT is a better diagnostic marker
of sepsis than CRP in a study comparing area under the ROC
curve, optimum predictive values, and optimum diagnostic
cutoff values for PCT and CRP.25
The diagnosis of sepsis is difficult in neonates who are
admitted to the NICU due to nonspecific clinical signs.
Therefore, reliable indicators of sepsis would be helpful in
an accurate diagnosis, resulting in a decrease in the un-
necessary use of antibiotics. In this study, we investigated
the practical use of resistin in the diagnosis of neonatal
sepsis and compared it with the other markers. The cutoff
value for resistin that can be used to discriminate the ba-
bies with sepsis from healthy babies was found to be 50 ng/
mL. The sensitivity, specificity, positive, and negative
predictive values for this cutoff value were found to be
74%, 46%, 68%, and 52%, respectively. The area under the
curve was 0.74 for resistin; however, the values for the
remaining parameters, such as CRP, PCT, and IL-6 were
0.94, 0.86, and 0.83, respectively. As can be seen
here, these markers, which are frequently used in the
diagnosis of neonatal sepsis, have more priority for the
diagnosis.
In conclusion, plasma resistin levels were significantly
increased in premature babies with sepsis. Increased levels
of resistin and also correlations found with the IL-6 levels
(which is a frequently used marker of neonatal sepsis)
suggest that resistin may be used as an indicator of sepsis in
preterm babies. However, it has a limited value compared
with other inflammatory markers, including CRP, PCT, and
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